Instil Bio Inc
|Market Cap (Intraday)||160.94M|
|2yr Forward PE||N/A|
Instil Bio Inc Stock, NASDAQ:TIL
Instil Bio, Inc. is a clinical-stage biopharmaceutical company engaged in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX.